No Data
Press Release: Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to Nevada
Trending Stocks Today | PainReform Surges 427.18%
Top Premarket Gainers
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Elevai Labs Subsidiary Announces FDA Regulatory Pathway for EL-22
Express News | Elevai Biosciences Announces Next Steps In Regulatory Strategy For EL-22, Prepareing For Pre-IND Meeting With FDA Anticipated In First Quarter Of 2025
No Data
